S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
Log in

NYSE:DHRDanaher Stock Price, Forecast & News

$141.94
+6.79 (+5.02 %)
(As of 04/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$138.63
Now: $141.94
$142.75
50-Day Range
$121.39
MA: $145.14
$165.95
52-Week Range
$119.60
Now: $141.94
$169.19
Volume5.61 million shs
Average Volume3.48 million shs
Market Capitalization$98.92 billion
P/E Ratio35.05
Dividend Yield0.53%
Beta0.85
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Cepheid, a company which is developing a faster test for COVID-19, is a subsidiary of Danaher.
Read More
Danaher logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 3.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.28 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
CUSIP23585110
Phone202-828-0850

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.91 billion
Cash Flow$6.53 per share
Book Value$39.93 per share

Profitability

Net Income$3.01 billion

Miscellaneous

Employees60,000
Market Cap$98.92 billion
Next Earnings Date4/16/2020 (Estimated)
OptionableOptionable

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.


Danaher (NYSE:DHR) Frequently Asked Questions

How has Danaher's stock been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 1.8% and is now trading at $141.94. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Danaher?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Danaher.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, April 16th 2020. View our earnings forecast for Danaher.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) posted its quarterly earnings data on Thursday, January, 30th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.25 by $0.03. The conglomerate had revenue of $4.87 billion for the quarter, compared to analysts' expectations of $4.80 billion. Danaher had a return on equity of 11.50% and a net margin of 15.09%. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.28 earnings per share. View Danaher's earnings history.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Thursday, February 20th. Stockholders of record on Friday, March 27th will be given a dividend of $0.18 per share on Friday, April 24th. This represents a $0.72 annualized dividend and a yield of 0.51%. The ex-dividend date of this dividend is Thursday, March 26th. This is a boost from Danaher's previous quarterly dividend of $0.17. View Danaher's dividend history.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its FY20 earnings guidance on Thursday, January, 30th. The company provided EPS guidance of $4.80 to $4.90 for the period, compared to the Thomson Reuters consensus estimate of $5.38.

What price target have analysts set for DHR?

14 brokers have issued 12 month target prices for Danaher's stock. Their forecasts range from $136.00 to $188.00. On average, they anticipate Danaher's share price to reach $164.44 in the next year. This suggests a possible upside of 15.9% from the stock's current price. View analysts' price targets for Danaher.

Has Danaher been receiving favorable news coverage?

Media coverage about DHR stock has trended very negative on Monday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Danaher earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the conglomerate a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutDanaher.

Are investors shorting Danaher?

Danaher saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 6,786,500 shares, an increase of 23.4% from the February 27th total of 5,500,000 shares. Based on an average daily trading volume, of 10,000,000 shares, the days-to-cover ratio is presently 0.7 days. Approximately 1.1% of the shares of the stock are sold short. View Danaher's Current Options Chain.

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Alphabet (GOOG), Cisco Systems (CSCO), Alibaba Group (BABA), Intel (INTC), CVS Health (CVS), Honeywell International (HON) and Adobe (ADBE).

Who are Danaher's key executives?

Danaher's management team includes the following people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 59)
  • Mr. Daniel L. Comas, Exec. VP (Age 56)
  • Mr. William K. Daniel II, Exec. VP (Age 55)
  • Mr. Rainer M. Blair, Exec. VP (Age 56)
  • Mr. Joakim Weidemanis, Exec. VP (Age 50)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Park National Corp OH (0.02%), Neville Rodie & Shaw Inc. (0.01%), Bath Savings Trust Co (0.01%), McGuire Investment Group LLC (0.01%), Fulton Bank N.A. (0.00%) and M&R Capital Management Inc. (0.00%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View institutional ownership trends for Danaher.

Which major investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Park National Corp OH, Neville Rodie & Shaw Inc., M&R Capital Management Inc., and McGuire Investment Group LLC. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Robert S Lutz, Thomas Patrick Joyce Jr, William K Daniel, and William King. View insider buying and selling activity for Danaher.

Which major investors are buying Danaher stock?

DHR stock was purchased by a variety of institutional investors in the last quarter, including Fulton Bank N.A., Thomasville National Bank, Bath Savings Trust Co, and Bangor Savings Bank. View insider buying and selling activity for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $141.94.

How big of a company is Danaher?

Danaher has a market capitalization of $98.92 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe. View additional information about Danaher.

What is Danaher's official website?

The official website for Danaher is http://www.danaher.com/.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Overbought

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel